ResApp Health (ASX:RAP) Share Price and News - StockTrack

Market Cap (26-Sep) $176,237,888 (1,192nd)	Close (28-Sep) $0.205 0 (0%)	Volume (28-Sep) 0	Shortsold (21-Sep) 297,501 (0.03%) (573rd)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.009

	Subject
	RAP RAP Ann: First patients recruited in COVID-19 clinical study in India
	1 (current) 2 3
	RAP RAP Ann: ResApp receives Advanced and Overseas R&D Finding
	RAP RAP Ann: ResAppDx receives regulatory approval in Indonesia
	RAP RAP Ann: Appendix 4G
	RAP RAP Ann: Corporate Governance Statement
	RAP RAP Ann: Appendix 4E and Annual Report
	RAP RAP Ann: Investor Webinar Presentation
	RAP RAP Ann: ResApp expands COVID-19 clinical program
	RAP RAP Ann: Alodokter to launch ResAppDx in Indonesia
	RAP RAP Ann: Medgate enters licence agreement with ResApp Health
	RAP RAP Ann: Trading Halt
	RAP RAP Ann: Quarterly Activities Report and Appendix 4C
	RAP RAP Ann: Quarterly Results and Investor Conference Call Notification
	RAP RAP Ann: Commercial agreement with Doctors on Demand in Australia
	RAP RAP Ann: ResApp study data published in peer-reviewed journal
	RAP RAP Ann: Notification of cessation of securities - RAP
	RAP RAP Ann: ResApp to present at the Gold Coast Investment Showcase
	RAP RAP Ann: Medgate extends European ResAppDx trial
	RAP RAP Ann: Corporate Overview Presentation
	RAP RAP Ann: Initial Director's Interest Notice
	RAP RAP Ann: Brian Leedman Reappointed as Executive Director
	RAP RAP Ann: First participant recruited in COVID-19 cough study
	RAP RAP Ann: Agreement with Ilara Health to sell ResAppDx in Kenya
	RAP RAP Ann: Quarterly Activities Report and Appendix 4C
	RAP RAP Ann: Quarterly Results and Investor Conference Call Notification
	RAP RAP Ann: Change in substantial holding
	RAP RAP Ann: Ceasing to be a substantial holder
	RAP RAP Ann: Appendix 3G
	RAP RAP Ann: Section 708A Notice and Appendix 2A
	RAP RAP Ann: Proposed issue of Securities - RAP
	RAP RAP Ann: ResApp secures firm commitments to raise $5.5 million
	RAP RAP Ann: Trading Halt
	RAP RAP Ann: Appendix 3G
	RAP RAP Ann: TGA clearance achieved for wearable
	RAP RAP Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
	RAP RAP Ann: Change of Director's Interest Notice - Tony Keating
	RAP RAP Ann: Change of Director's Interest Notice - Roger Aston
	RAP RAP Ann: Change in substantial holding
	RAP RAP Ann: Change in substantial holding
	RAP RAP Ann: Section 708A Notice and Appendix 2A
	RAP RAP Ann: S&P DJI Announces March 2021 Quarterly Rebalance
	RAP RAP Ann: ResApp grants SDK licence to AstraZeneca for asthma program
	RAP RAP Ann: Clinical study to develop COVID-19 screening test
	RAP RAP Ann: Medgate commences European ResAppDx trial
	RAP RAP Ann: Proposed issue of Securities - RAP
	RAP RAP Ann: CE Mark achieved for wearable device
	RAP RAP Ann: Update on Licencing Agreement with WMA
	RAP RAP Ann: Resignation of Joint Company Secretary
	RAP RAP Ann: Appendix 4D and Half Year Financial Report
	RAP RAP Ann: Pre-Submission package lodged with the US FDA

Similar Companies

4DMedical

4DX

Alcidion Group

ALC

Cogstate

CGS

ImExHS

IME

Mach7 Technologies

M7T

MedAdvisor

MDR

PainChek

PCK

PKS Holdings

PKS

Pro Medicus

PME

End of Day Prices

Date	Close	Volume	Change
26-Sep	$0.21	0	0.00 (0.00%)
23-Sep	$0.21	0	0.00 (0.00%)
21-Sep	$0.21	0	0.00 (0.00%)
20-Sep	$0.21	0	0.00 (0.00%)
19-Sep	$0.21	0	0.00 (0.00%)
16-Sep	$0.21	0	0.00 (0.00%)
15-Sep	$0.21	2,715,724	-0.01 (2.38%)
14-Sep	$0.21	4,737,693	+0.01 (2.44%)
13-Sep	$0.21	2,870,267	0.00 (0.00%)
12-Sep	$0.21	13,438,734	0.00 (0.00%)
09-Sep	$0.21	6,140,713	0.00 (0.00%)
08-Sep	$0.21	6,700,467	0.00 (0.00%)
07-Sep	$0.21	36,730,379	0.00 (0.00%)
06-Sep	$0.21	16,491,638	+0.00 (2.50%)
05-Sep	$0.20	24,510,980	0.00 (0.00%)
2 up, 1 down, and 12 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
1 July 2025 at 5:04am

High -	Low -	Trades -	Turnover $0	Volume 0
1 July 2025 at 5:04am

ResApp Health Health Care

$0.205 (0%)

$0.205 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices